EDGAR Filing Documents for 0001213900-21-001774

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001213900-21-001774

Filing Date

2021-01-13

Accepted

2021-01-12 19:51:24

Documents

Effectiveness Date

2021-01-13

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	6830
	Complete submission text file	0001213900-21-001774.txt		7888

Mailing Address 1013 CENTRE ROAD SUITE 403-B WILMINGTON DE 19805

Business Address 670-21,SANNAE-RO, SANNAE-MYEON MIRYANG-SI, GYEONGSANGNAM-DO M5 50414 780-448-1400

ONCOQUEST PHARMA USA, INC (Filer) CIK: 0001839861 (see all company filings)